Literature DB >> 19361896

Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation.

Vladimir V Kouznetsov1, Alicia Gómez-Barrio.   

Abstract

A short history of hybrid molecules based on aminoquinolines gave interesting and important information useful for organic and medicinal chemistry, which are deeply involved in the design and development of new antimalarial agents. The highlights in the preparation of aminoquinoline antimalarials, their protocols and antiplasmodial activity and, specially, the development on hybridization approaches are represented.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361896     DOI: 10.1016/j.ejmech.2009.02.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

1.  Novel 4-aminoquinoline-pyrimidine based hybrids with improved in vitro and in vivo antimalarial activity.

Authors:  Sunny Manohar; U Chinna Rajesh; Shabana I Khan; Babu L Tekwani; Diwan S Rawat
Journal:  ACS Med Chem Lett       Date:  2012-06-10       Impact factor: 4.345

2.  2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies.

Authors:  Kamaljit Singh; Hardeep Kaur; Kelly Chibale; Jan Balzarini; Susan Little; Prasad V Bharatam
Journal:  Eur J Med Chem       Date:  2012-03-13       Impact factor: 6.514

3.  Antineoplastic agents. 592. Highly effective cancer cell growth inhibitory structural modifications of dolastatin 10.

Authors:  George R Pettit; Fiona Hogan; Steven Toms
Journal:  J Nat Prod       Date:  2011-05-02       Impact factor: 4.050

4.  Methemoglobinemia caused by 8-aminoquinoline drugs: DFT calculations suggest an analogy to H4B's role in nitric oxide synthase.

Authors:  Haining Liu; Larry A Walker; N P Dhammika Nanayakkara; Robert J Doerksen
Journal:  J Am Chem Soc       Date:  2011-01-18       Impact factor: 15.419

5.  Huprines as a new family of dual acting trypanocidal-antiplasmodial agents.

Authors:  Julien Defaux; Marta Sala; Xavier Formosa; Carles Galdeano; Martin C Taylor; Waleed A A Alobaid; John M Kelly; Colin W Wright; Pelayo Camps; Diego Muñoz-Torrero
Journal:  Bioorg Med Chem       Date:  2011-01-21       Impact factor: 3.641

6.  4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity.

Authors:  Igor M Opsenica; Mikloš Tot; Laura Gomba; Jonathan E Nuss; Richard J Sciotti; Sina Bavari; James C Burnett; Bogdan A Solaja
Journal:  J Med Chem       Date:  2013-07-12       Impact factor: 7.446

7.  Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design.

Authors:  Francis W Muregi; Akira Ishih
Journal:  Drug Dev Res       Date:  2010-02       Impact factor: 4.360

8.  Design and Synthesis of Novel Hybrid Molecules against Malaria.

Authors:  Melanie Lödige; Luisa Hiersch
Journal:  Int J Med Chem       Date:  2015-02-05

9.  Microwave-assisted Cu(I)-catalyzed, three-component synthesis of 2-(4-((1-phenyl-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-1H-benzo[d]imidazoles.

Authors:  Yogesh Kumar; Vijay Bahadur; Anil Kumar Singh; Virinder Singh Parmar; Erik V Van der Eycken; Brajendra Kumar Singh
Journal:  Beilstein J Org Chem       Date:  2014-06-24       Impact factor: 2.883

10.  Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria.

Authors:  Milica Videnović; Dejan M Opsenica; James C Burnett; Laura Gomba; Jonathan E Nuss; Zivota Selaković; Jelena Konstantinović; Maja Krstić; Sandra Segan; Mario Zlatović; Richard J Sciotti; Sina Bavari; Bogdan A Solaja
Journal:  J Med Chem       Date:  2014-05-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.